119 related articles for article (PubMed ID: 18775458)
1. Characterization of a conformationally sensitive TOAC spin-labeled substance P.
Shafer AM; Nakaie CR; Deupi X; Bennett VJ; Voss JC
Peptides; 2008 Nov; 29(11):1919-29. PubMed ID: 18775458
[TBL] [Abstract][Full Text] [Related]
2. The role of the N-terminal and mid-region residues of substance P in regulating functional selectivity at the tachykinin NK1 receptor.
Perrine SA; Beard DJ; Young JK; Simmons MA
Eur J Pharmacol; 2008 Sep; 592(1-3):1-6. PubMed ID: 18634782
[TBL] [Abstract][Full Text] [Related]
3. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
Ciucci A; Palma C; Manzini S; Werge TM
Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
[TBL] [Abstract][Full Text] [Related]
4. Conformational analysis of the C-terminal Gly-Leu-Met-NH2 tripeptide of substance P bound to the NK-1 receptor.
Sagan S; Quancard J; Lequin O; Karoyan P; Chassaing G; Lavielle S
Chem Biol; 2005 May; 12(5):555-65. PubMed ID: 15911376
[TBL] [Abstract][Full Text] [Related]
5. Probing the binding pocket and endocytosis of a G protein-coupled receptor in live cells reported by a spin-labeled substance P agonist.
Shafer AM; Bennett VJ; Kim P; Voss JC
J Biol Chem; 2003 Sep; 278(36):34203-10. PubMed ID: 12821667
[TBL] [Abstract][Full Text] [Related]
6. p-(4-Hydroxybenzoyl)phenylalanine: a photoreactive amino acid analog amenable to radioiodination for elucidation of peptide-protein interaction. Application to substance P receptor.
Wilson CJ; Husain SS; Stimson ER; Dangott LJ; Miller KW; Maggio JE
Biochemistry; 1997 Apr; 36(15):4542-51. PubMed ID: 9109663
[TBL] [Abstract][Full Text] [Related]
7. Peptide-lipid interaction monitored by spin labeled biologically active melanocortin peptides.
Fernandez RM; Vieira RF; Nakaie CR; Ito AS; Lamy MT
Peptides; 2005 Oct; 26(10):1825-34. PubMed ID: 16006009
[TBL] [Abstract][Full Text] [Related]
8. The use of spin-labeled ligands as biophysical probes to report real-time endocytosis of G protein-coupled receptors in living cells.
Shafer A; Voss J
Sci STKE; 2004 May; 2004(232):pl9. PubMed ID: 15138329
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of vinylogous scaffolds in the C-terminal tripeptide of substance P.
Claudel S; Tasseau O; Sagan S; Grison C; Coutrot P; Lavielle S
J Pept Res; 2004 Nov; 64(5):186-93. PubMed ID: 15485556
[TBL] [Abstract][Full Text] [Related]
10. Neurokinin-1 receptor resensitization precedes receptor recycling.
Bennett VJ; Perrine SA; Simmons MA
J Pharmacol Exp Ther; 2005 Jun; 313(3):1347-54. PubMed ID: 15764733
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
[TBL] [Abstract][Full Text] [Related]
12. Functional selectivity of NK1 receptor signaling: peptide agonists can preferentially produce receptor activation or desensitization.
Simmons MA
J Pharmacol Exp Ther; 2006 Nov; 319(2):907-13. PubMed ID: 16916996
[TBL] [Abstract][Full Text] [Related]
13. Spin-labeled extracellular loop from a seven-transmembrane helix receptor: studies in solution and interaction with model membranes.
Pertinhez TA; Nakaie CR; Paiva AC; Schreier S
Biopolymers; 1997 Dec; 42(7):821-9. PubMed ID: 10904553
[TBL] [Abstract][Full Text] [Related]
14. Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology.
Mellentin-Michelotti J; Evangelista LT; Swartzman EE; Miraglia SJ; Werner WE; Yuan PM
Anal Biochem; 1999 Aug; 272(2):182-90. PubMed ID: 10415087
[TBL] [Abstract][Full Text] [Related]
15. Biological activity of silylated amino acid containing substance P analogues.
Cavelier F; Marchand D; Martinez J; Sagan S
J Pept Res; 2004 Mar; 63(3):290-6. PubMed ID: 15049841
[TBL] [Abstract][Full Text] [Related]
16. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
17. Backbone dynamics determined by electron paramagnetic resonance to optimize solid-phase peptide synthesis of TOAC-labeled phospholamban.
Zhang Z; Remmer HA; Thomas DD; Karim CB
Biopolymers; 2007; 88(1):29-35. PubMed ID: 17066471
[TBL] [Abstract][Full Text] [Related]
18. Systematic study of substance P analogs. I. Evaluation of peptides synthesized by the multipin method for quantitative receptor binding assay.
Wang JX; Bray AM; Dipasquale AJ; Maeji NJ; Geysen HM
Int J Pept Protein Res; 1993 Oct; 42(4):384-91. PubMed ID: 7503963
[TBL] [Abstract][Full Text] [Related]
19. Internalization of [3H]substance P analogues in NK-1 receptor transfected CHO cells.
Sagan S; Lavielle S
Biochem Biophys Res Commun; 2001 Apr; 282(4):958-64. PubMed ID: 11352645
[TBL] [Abstract][Full Text] [Related]
20. Calpha methylation in molecular recognition. Application to substance P and the two neurokinin-1 receptor binding sites.
Sagan S; Lequin O; Frank F; Convert O; Ayoub M; Lavielle S; Chassaing G
Eur J Biochem; 2001 May; 268(10):2997-3005. PubMed ID: 11358518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
